Orsythia
Product Images NDC 50090-4303

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orsythia (NDC 50090-4303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904303)

The image shows a drug facts label for Orsythia by A-S Medication Solutions. It lists the active ingredients as levonorgestrel 0.1 mg and ethinyl estradiol 0.02 mg. The label includes storage instructions to keep the product at 68 to 77 degrees Fahrenheit and indicates the package contains 28 blister cards. The label also shows a product number 6442-0 and a National Drug Code (NDC) 50090-4303-0.*

FDA Label Image

Chemical Structure (Orsythia 0254 1)

Chemical structure diagrams of Levonorgestrel and Ethinyl Estradiol are shown. Each structure is labeled with the corresponding chemical formula and molecular weight: Levonorgestrel (C21H28O2, MW 312.4) and Ethinyl Estradiol (C20H24O2, MW 296.4).*

FDA Label Image

Figure 1 (Orsythia 0254 2)

A dual-panel pharmacokinetic chart showing concentration over time for levonorgestrel and ethinyl estradiol. The x-axis represents time in hours (0 to 80), and the y-axis shows concentration (ng/mL for levonorgestrel, pg/mL for ethinyl estradiol). Data points illustrate measurements on Day 1, Day 6, and Day 21, with declining concentrations over time for both hormones.*

FDA Label Image

Figure 2.jpg (Orsythia 0254 3)

Bar graph depicting data categorized by age groups (15-24, 25-34, 35-44, 45+) and user status (ever-users and controls, both nonsmokers and smokers). The y-axis represents a numerical scale up to 200. The highest bar appears in the 45+ ever-users (smokers) category.*

FDA Label Image

Blister Image (Orsythia 0254 4)

An instructional diagram for Orsythia tablets (0.01 mg ethinyl estradiol and 0.2 mg drospirenone) showing a 28-day dosage schedule. The weekly layout is in four rows labeled Week 1 to Week 4, each with daily circles from Sunday to Saturday. Weeks 1-3 circles are empty, Week 4 circles are filled, indicating active and inactive tablet days.*

FDA Label Image

Blister Image (Orsythia 0254 5)

Weekly pill calendar diagram for Orsythia (0.1 mg ethinyl estradiol and 0.2 mg drospirenone tablets), designed to guide daily oral intake over four weeks. The first three weeks feature empty circles for active tablets intake, while the fourth week has shaded circles indicating placebo or non-hormonal tablets, with days labeled from Sunday to Saturday.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.